View abstract

Cet abstract a été assigné à session Ped & Low - Pediatric Ophthalmology and Low-Vision
TitreOcular side effects of Vigabatrin in children
Abstract Nr.1079
ButVigabatrin is an inhibitor of GABA transaminase used for the treatment of infantile spasms and epilepsy refractory to others treatments. Unfortunately, it can be associated with permanent peripheral visual field defects that are difficult to detect in young patients.

The purpose is to update the recommended ophthalmologic follow up of children taking Vigabatrin.
MéthodesA literature review of visual loss related to Vigabatrin is presented. The screening tests, such as ophthalmoscopy, automated visual fields, SD OCT, ERG, VEP, will be reviewed.
RésultatsEpileptic patients may have visual defects not attributed to Vigabatrin. In non-verbal, uncooperative young patients, ophthalmoscopy is recommended at baseline and every 3 months
ConclusionPeriodic dilated ophthalmoscopy is the best method to avoid unnecessary cessation of this valuable medication in epileptic young patient.
Conflit d'intérêtNon
Auteur 1
NomYOUSSFI
InitialesAY
InstitutHôpital Erasme
VilleBruxelles
top ^